We are pleased to advise that the Office of Drug Control has now approved LeafCann’s Cannabis Manufacturing Licence.

The Narcotic Drugs Amendment in February 2016 means Victoria is the first Australian state to legalise the manufacture and supply of medical cannabis to support people in chronic pain. 

LeafCann Medical Cannabis is striving to be the first triple P (People, Planet, Profit) medical cannabis grower in Australia. Our primary focus will be to provide high quality, cannabis products to patients across Australia, growing a loyal base of customers with our fair prices and sustainable commitment to community and charity. 

It’s our aim to become industry thought leaders through our partnerships with universities and other medical research organisations.
With headquarters in South Australia, a world-class management team and expert advisory board, our commercial ‘Seed to Sale’ model focuses on Australian-based cultivation, research and development, manufacturing and distribution of medical cannabis.


Creating a new agricultural industry with a focus on genetic acquisition and breeding new medicines for the Australian medicinal cannabis market.  

LC 361 2016_Web Design 1_graph42.jpg


LeafCann will produce a range of Activated Pharmaceutical Ingredients (APIs), including whole plant extracts, bespoke extracts and isolates, and finished products under GMP.


Facilitate a range of diverse research initiatives , including: Genetics development, Agriculture & Horticulture, Extraction processes and product formulation and development. 


The LeafCann ethos of Patient before Profit will ensure our customers are well educated and safe, with access to quality products at an affordable price. 


At LeafCann we want to give patients a constant, easy to access supply of the highest quality medical cannabis products.

That’s why we spent a lot of time researching the best controlled environment GMP Indoor production, complemented by GACP Greenhouse partners.

So how does it work? LeafCann’s production methodology simulates ideal growing conditions for each cultivar to support expression of key cannabinoids, terpenes and other plant molecules in the desired ratios, resulting in high quality, safe and effective end products.

That’s great news for patients and investors because it means that LeafCann will be able to deliver a high quality product at a price that’s fair for everyone. 





LC 361_Web Design Assets_GraphicSeedToSale.jpg